InMed Pharmaceuticals (INM) Current Leases: 2021-2025
Historic Current Leases for InMed Pharmaceuticals (INM) over the last 4 years, with Sep 2025 value amounting to $424,765.
- InMed Pharmaceuticals' Current Leases rose 0.12% to $424,765 in Q3 2025 from the same period last year, while for Sep 2025 it was $424,765, marking a year-over-year increase of 0.12%. This contributed to the annual value of $435,507 for FY2025, which is 37.04% up from last year.
- Per InMed Pharmaceuticals' latest filing, its Current Leases stood at $424,765 for Q3 2025, which was down 2.47% from $435,507 recorded in Q2 2025.
- In the past 5 years, InMed Pharmaceuticals' Current Leases registered a high of $435,507 during Q2 2025, and its lowest value of $82,232 during Q3 2021.
- Over the past 3 years, InMed Pharmaceuticals' median Current Leases value was $419,711 (recorded in 2024), while the average stood at $386,664.
- In the last 5 years, InMed Pharmaceuticals' Current Leases skyrocketed by 391.49% in 2022 and then fell by 27.50% in 2023.
- Over the past 5 years, InMed Pharmaceuticals' Current Leases (Quarterly) stood at $391,805 in 2021, then climbed by 5.74% to $414,307 in 2022, then fell by 12.10% to $364,190 in 2023, then grew by 15.25% to $419,711 in 2024, then increased by 0.12% to $424,765 in 2025.
- Its Current Leases was $424,765 in Q3 2025, compared to $435,507 in Q2 2025 and $429,247 in Q1 2025.